000 | 01617 a2200457 4500 | ||
---|---|---|---|
005 | 20250514220702.0 | ||
264 | 0 | _c20050524 | |
008 | 200505s 0 0 eng d | ||
022 | _a0301-0430 | ||
024 | 7 |
_a10.5414/cnp63080 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKamar, N | |
245 | 0 | 0 |
_aAssessment of glomerular and tubular functions in renal transplant patients receiving cyclosporine A in combination with either sirolimus or everolimus. _h[electronic resource] |
260 |
_bClinical nephrology _cFeb 2005 |
||
300 |
_a80-6 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aEverolimus |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGlomerular Filtration Rate _xdrug effects |
650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
650 | 0 | 4 | _aKidney Transplantation |
650 | 0 | 4 |
_aKidney Tubules _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
650 | 0 | 4 |
_aSirolimus _xadministration & dosage |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aAllard, J | |
700 | 1 | _aRibes, D | |
700 | 1 | _aDurand, D | |
700 | 1 | _aAder, J L | |
700 | 1 | _aRostaing, L | |
773 | 0 |
_tClinical nephrology _gvol. 63 _gno. 2 _gp. 80-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.5414/cnp63080 _zAvailable from publisher's website |
999 |
_c15404774 _d15404774 |